Repligen Corporation (RGEN)
Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Anthony J. Hunt | CEO & Director | 885k | -- | 1964 |
| Mr. Olivier Loeillot | President & Chief Commercial Officer | 1.49M | -- | 1970 |
| Mr. James R. Bylund | Chief Operating Officer | 472.18k | -- | 1964 |
| Ms. Christine Gebski | Senior Vice President of Filtration & Chromatography | 396.09k | -- | 1968 |
| Mr. Ralf Kuriyel | Senior Vice President of Research & Development | 401.74k | -- | 1958 |
| Mr. Keith Lee Robinson | Chief Information Officer | -- | -- | -- |
| Ms. Sondra S. Newman | Global Head of Investor Relations | -- | -- | -- |
| Mr. Kola Otitoju | Senior Vice President of Strategy & Business Development | -- | -- | -- |
| Dianne Heiler | Senior Director of Packaging & Sustainability | -- | -- | -- |
Repligen Corporation
- Sector:
- Healthcare
- Industry: Medical Instruments & Supplies
- Full Time Employees:
- 1,783
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Corporate Governance
Recent Events
- Apr 01, 2024DEF 14A: Proxy StatementsSee Full Filing
- Mar 19, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 22, 202410-K: Periodic Financial ReportsSee Full Filing
- Feb 21, 20248-K: Corporate Changes & Voting MattersSee Full Filing
- Feb 14, 2024SC 13G/A: Tender Offer/Acquisition ReportsSee Full Filing